Beyond the Guidelines: Promising Practices to Improve the Care of Patients With Pulmonary Fibrosis

This activity has been designed to meet the educational needs of healthcare providers in interstitial lung disease centers, both in the Pulmonary Fibrosis Foundation Care Center Network and outside the Network, including physicians, registered and advanced practice nurses, physician assistants, and nurse practitioners. Interstitial lung disease centers’ consultative personnel, including cardiologists, gastroenterologists, geneticists/counselors, infectious disease specialists, psychiatrists/psychologists, sleep medicine specialists, pathologists (pulmonary), radiologists (thoracic), rheumatologists, surgeons (general/thoracic), and community pulmonologists may also be interested in the activity.

Supported by educational grants from:

Genentech and Boehringer Ingelheim

Activity Information

Original Release Date: December 31, 2017
Expiration Date: December 31, 2018
Estimated Time to Complete Activity: 1.0 hour

Method of Participation

Participants should read the activity information, review the activity in its entirety, and complete the online posttest and evaluation. Upon completing this activity as designed and achieving a passing score on the posttest, you will be directed to a web page that will allow you to receive your certificate of credit via email or you may print it out at that time.
The online posttest and evaluation can be accessed at: https://tinyurl.com/IPFBrtSp17. Inquiries may be directed to Global Academy for Medical Education at info@globalacademycme.com or (973) 290-8225 or the Postgraduate Institute for Medicine at (720) 895-5357.

Accreditation Statements

Physicians: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Postgraduate Institute for Medicine and Global Academy for Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: The Postgraduate Institute for Medicine is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This educational activity for 1.0 contact hour is provided by the Postgraduate Institute for Medicine.

Program Overview

Idiopathic pulmonary fibrosis is a progressive interstitial lung disease with poor prognosis and no cure. Despite the availability of evidence-based guidelines, significant gaps in care remain, including delayed or inaccurate diagnosis, delayed referral to specialty care, limited use of recommended multidisciplinary (interprofessional) care, variable approaches to management, and poor patient-provider communication. The Pulmonary Fibrosis Foundation Care Center Network has the potential to improve patient outcomes by sharing local expertise and clinical excellence in idiopathic pulmonary fibrosis diagnosis and disease management with other care center network sites and community clinicians.

Thus, one of its goals is to bring together the collective resources of centers and facilitate intercenter communication to establish current standards of practice. This monograph reflects interviews with personnel at five Pulmonary Fibrosis Foundation Care Center Network sites who provided self-reflection on what they do well in the care of their patients with pulmonary fibrosis.

Learning Objectives

  • Identify strategies to standardize the clinical management of patients with idiopathic pulmonary fibrosis
  • Describe strategies to increase patient education within the existing workflow of idiopathic pulmonary fibrosis patient management
  • Describe strategies to improve interprofessional collaboration related to the management of idiopathic pulmonary fibrosis

Disclosure of Conflicts of Interest

The Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COIs are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The planning staff and content managers hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Global Academy for Medical Education Staff: Sylvia H. Reitman, MBA, DipEd; Mike LoPresti; Shirley V. Jones, MBA; Ron Schaumburg; and Stephanie Breslan, MS; hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Postgraduate Institute for Medicine: The following planners and managers, Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, CHCP; Judi Smelker-Mitchek, MBA, MSN, RN; and Jan Schultz, MSN, RN, CHCP; have nothing to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.